Hyaluronidase
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections.
6,317 FDA drug recalls with this cause, newest first.
This is the single biggest cause in the register by a wide margin. It covers products that had to be sterile - injectables, eye drops, certain ointments - but could not be verified sterile, or were found contaminated during testing. Most of these recalls come from compounding pharmacies and outsourcing facilities after an FDA inspection finds gaps in how sterile products were made. Sterility failures are treated seriously because the products involved have the least room for error, going straight into the bloodstream or the eye.
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Lack of Sterility Assurance: The product has the potential to leak at the administrative port.
Lack of Assurance of Sterility; increased complaints received for leaks
Lack of Assurance of Sterility; increased complaints received for leaks
Lack of Assurance of Sterility. Complaints were receive of missing closures and/or leaks which may compromise product sterility.
Lack of Assurance of Sterility. Complaints were receive of missing closures and/or leaks which may compromise product sterility.
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Non-Sterility: Confirmed customer report of dark, fibrous particulates floating within the solution of the primary container, which were subsequently identified as mold
Lack of Assurance of Sterility. A recent FDA inspection reported GMP violations potentially impacting product quality and sterility.
Lack of Assurance of Sterility: there is a potential for solution to leak at the administrative port of the primary container.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.